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AbstrACt
Objective The objective of this analysis was to examine 
trends in malaria parasite prevalence and related 
socioeconomic inequalities in malaria indicators from 2006 
to 2013 during a period of intensification of malaria control 
interventions in Siaya County, western Kenya.
Methods Data were analysed from eight independent 
annual cross-sectional surveys from a combined sample of 
19 315 individuals selected from 7253 households. Study 
setting was a health and demographic surveillance area 
of western Kenya. Data collected included demographic 
factors, household assets, fever and medication use, malaria 
parasitaemia by microscopy, insecticide-treated bed net 
(ITN) use and care-seeking behaviour. Households were 
classified into five socioeconomic status and dichotomised 
into poorest households (poorest 60%) and less poor 
households (richest 40%). Adjusted prevalence ratios (aPR) 
were calculated using a multivariate generalised linear 
model accounting for clustering and cox proportional hazard 
for pooled data assuming constant follow-up time.
results Overall, malaria infection prevalence was 36.5% 
and was significantly higher among poorest individuals 
compared with the less poor (39.9% vs 33.5%, aPR=1.17; 
95% CI 1.11 to 1.23) but no change in prevalence over 
time (trend p value <0.256). Care-seeking (61.1% vs 
62.5%, aPR=0.99; 95% CI 0.95 to 1.03) and use of any 
medication were similar among the poorest and less poor. 
Poorest individuals were less likely to use Artemether-
Lumefantrine or quinine for malaria treatment (18.8% vs 
22.1%, aPR=0.81, 95% CI 0.72 to 0.91) while use of ITNs 
was lower among the poorest individuals compared with 
less poor (54.8% vs 57.9%; aPR=0.95; 95% CI 0.91 to 
0.99), but the difference was negligible.
Conclusions Despite attainment of equity in ITN use 
over time, socioeconomic inequalities still existed in 
the distribution of malaria. This might be due to a lower 
likelihood of treatment with an effective antimalarial 
and lower use of ITNs by poorest individuals. Additional 
strategies are necessary to reduce socioeconomic 
inequities in prevention and control of malaria in endemic 
areas in order to achieve universal health coverage and 
sustainable development goals.
bACkgrOund
Malaria is a global health problem and WHO 
reported that in 2017 there were 219 million 
cases and 435 million deaths compared with 
239 million cases in 2010 (95% CI 219 to 
285 million) while in 2016, the cases were 
217 million (95% CI 200 to 259 million).1 
A recent WHO report revealed there had 
been a stagnation in progress in reducing 
burden between 2015 and 2017.1 Approx-
imately 93% of all malaria deaths in 2017, 
and 90% of the estimated 445 000 malaria 
deaths worldwide occurred in the Africa 
region in 2016.2 Despite massive distribution 
strengths and limitations of this study
 ► Eight years of repeated annual cross-sectional 
pooled data provided more power to assess trends 
in socioeconomic inequalities and equity in malaria 
indicators over time. Such data have not been pub-
lished in this setting.
 ► Use of data from repeated cross-sectional studies 
provides opportunity to monitor trends in malaria 
burden, socioeconomic inequalities and potential 
equity gaps or gains as malaria control interventions 
are intensified over time.
 ► The main limitations included; use of cross-sec-
tional surveys which prevented any evaluation of 
cause-and-effect of socioeconomic status and poli-
cy interventions on malaria indicators over time.
 ► Only households with children <5 years and a por-
tion of persons ≥5 years were included in the sur-
veys based on protocol-specific objectives due to 
the need to ensure every households had at least 
under 5, who had been the main target for interven-
tions over time.
 ► Different sampling procedure was used in 1 year 
(2009) and may have resulted in selection bias of 
participants.
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of malaria control interventions, a recent study showed 
that there still exists shortfalls and inequities in burden, 
coverage and utilisations of interventions.3 Another study, 
however, showed that massive insecticide-treated bed nets 
(ITN) distribution favoured the poorest households in 
most settings hence increasing equity.4 In western Kenya, 
malaria is a major cause of morbidity and mortality with 
more than 70% of the population at risk.5 In 2015, the 
prevalence of microscopically confirmed malaria among 
children <15 years of age was 8% nationally and 27% in 
the lake-endemic region of western Kenya.5 In western 
Kenya, routine and unpublished data had showed that 
the prevalence of malaria remained fairly stable since 
2006 despite intensified control efforts during the study 
periods.
Government of Kenya and international partners spent 
approximated US$810 million on malaria preventions 
and treatment programmes6 which included distribu-
tion of long-lasting ITNs, indoor residual spraying (IRS) 
in selected areas, intermittent preventive treatment 
during pregnancy in malaria-endemic areas, and prompt 
and effective malaria case management.5 7 8 Since 2004, 
Kenya national guidelines provided that first-line treat-
ment for malaria was artemisinin-based combination 
therapies (ACT).9–11 By 2006, Artemether-Lumefantrine 
(AL), the first-line ACT, started becoming available in 
the public sector at no cost to patients, and the first free 
mass net distribution campaign targeting children <5 
years and pregnant women was conducted in malaria 
endemic and epidemic-prone areas.11–13 The second free 
mass net distribution campaign, with a goal of universal 
coverage (ie, one net per two people per household), 
was conducted in a phased approach from 2011 to 2012, 
with households in western Kenya receiving long lasting 
insecticide nets (LLINs) in 2011.14 Equitable distribution 
of health services or interventions is a principle advo-
cated for in most national policies documents to achieve 
universal health coverage.15 A recent paper outlined the 
five sustainable development goals (SDGs) set of targets 
that relate to the reduction of health inequalities nation-
ally and worldwide.16 The study listed the SDG targets as 
poverty reduction, health and well-being for all, equitable 
education, gender equality, and reduction of inequalities 
within and between countries.16
However, despite a national policy of free antimalarial 
medications for children <5 years in the public sector in 
Kenya and mass distribution of LLINs in Kenya, access 
and utilisation of health services has been previously 
shown to vary substantially across socioeconomic groups, 
which undermines achieving health equity and universal 
health coverage.17 However, there are no published data 
on the trends of socioeconomic inequalities in malaria 
indices over time in endemic areas on western Kenya.
A key pillar of the Kenya Health Policy 2014–2030 is to 
improve health indicators through equitable distribution 
of health services and interventions in line with the SDG 
to achieve universal access to safe, effective, quality and 
affordable healthcare services for all.15 Health inequality 
and equity data on malaria indicators are often collected 
but not analysed from an economic or equity perspective. 
Yet, such data and analyses are important for monitoring 
health inequalities and assessing the impact of malaria 
control interventions at the microeconomic level.18 
Trends in malaria burden and socioeconomic inequali-
ties between the poor and wealthier individuals has not 
been published in endemic western Kenya over time, yet 
socioeconomic inequalities are known barriers to health 
utilisation and control efforts.18–20 However, lack of longi-
tudinal data has undermined assessing trends in socio-
economic inequalities in malaria indices and potential 
equity effect of intensified control programme on equity 
at the household over time. The objective of this analysis 
was to use data from repeated cross-sectional surveys to 
examine the trends in malaria parasite prevalence and 
related socioeconomic inequalities in malaria indicators 
from 2006 to 2013 during a period of intensification of 
malaria control interventions in Siaya County, western 
Kenya.
MethOds
study design and site
Independent annual community-based, cross-sectional 
surveys were conducted between 2006 and 2013, between 
the months of April and July within the Kenya Medical 
Research Institute and Centers for Disease Control and 
Prevention Health and Demographic Surveillance System 
(HDSS) in Siaya County in western Kenya. The HDSS has 
been described in detail elsewhere.21 22 Briefly, HDSS 
covers a population of approximately 223 000 people 
residing in 393 villages located in three of six subcoun-
ties of Siaya County, an area of approximately 700 km2 
along the shores of Lake Victoria. The vast majority of 
the population are subsistence farmers and fishermen. 
Health indicators in Siaya County, part of the former 
Nyanza Province, are poor compared with national stan-
dards.23 24 Nyanza Province had the highest rates of child 
mortality and an estimated 60% of the population lived 
below poverty level during the survey period.25
Population and sampling strategies
A total of 19 315 individuals in 7253 households were 
surveyed between 2006 and 2013. Overall, 33.9% were 
children aged <5 years, 26.6% were children aged 
5–14 years and the remaining 39.5% were 15 years old 
adults. Sample size in 2006–2013 were (2006 n=1113; 
2007 n=1270; 2008 n=1830; 2009 n=2508; 2010 n=5334; 
2011 n=2129; 2012 n=2719; 2013 n=2412) and the mean 
annual sample was 2414 (table 1).
For each year from 2006 to 2013, different sampling 
strategies were selected for logistical purposes. System-
atic sampling technique was used from a sample frame of 
eligible households and individuals enrolled into HDSS 
except in 2009 when a cluster sampling was used (table 2). 
Households were selected for participation in the surveys 
if they had at least a child <5 years because many malaria 
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Table 2 Sampling size and techniques used to select individual participants in the surveys between 2006 and 2013
Month/Year Sampling techniques Total <5 year 5–14 years 15+ years
April 2006 Systematic random sampling 1113 255 306 552
April 2007 Systematic random sampling 1270 260 364 629
April 2008 Systematic random sampling 1830 296 509 950
April 2009 Cluster and stratified sampling 2508 628 725 1155
April 2010 Systematic random sampling 5334 1389 1744 2201
June 2011 Systematic random sampling 2129 921 500 708
June 2012 Systematic random sampling 2719 1545 473 701
June 2013 Systematic random sampling 2412 1229 495 688
Pooled   19 315 6523 5116 7584
control interventions targeted this age group. In the 
HDSS, each individual, household, compound and village 
is assigned a unique number. For the years when system-
atic sampling was used, a list of households and individ-
uals was made ordered by the unique identifiers and by 
villages which are spread over the entire study area. Once 
a sample size for the individuals required in each year, the 
number of households was estimated assuming a house-
hold had an average of five members. The households 
were then systematically sampled from the list. The indi-
viduals sampled were then classified as <5, 5–14 and 15 
years and above. In 2009, villages were randomly sampled 
as clusters and the number of households divided propor-
tionately between the three study areas. Surveys were 
conducted in Rarieda, Gem and Alego-Usonga subcoun-
ties in Siaya County except in 2006 when Alego-Usonga 
subcounty was not included.
data collection
During the surveys, study participants were interviewed by 
trained staff using personal digital assistants and tablets. 
Data collected included demographic factors, socioeco-
nomic factors including asset ownership, characteristics 
and utilities, care-seeking behaviours, history of fever in 
the 2 weeks before the survey, ITN use and antimalarial 
medication use both recommended and non-recom-
mended by polices.
During each survey, a blood specimen was obtained 
from all individuals providing consent in the sampled 
households using a finger prick and used for measure-
ment of haemoglobin (HemoCue; Ängelholm, Sweden) 
and to measure malaria parasitaemia by rapid diagnostic 
test (RDT) (Carestart Malaria HRP-2/pLDH (Pf/PAN) 
Combo, Somerset, New Jersey, USA). Individuals with a 
positive malaria RDT were treated in accordance with the 
Kenya national malaria treatment guidelines.10 12 26 Thick 
and thin blood smears were obtained for malaria species’ 
identification and parasite density.
data management and analysis
Data coding, recoding, merging and analysis were 
conducted in Stata V.14. The eight cross sectional surveys 
were first analysed independently and then as pooled data. 
The key variables were identified for each year and then 
appended to each other to form a large dataset. Consid-
ering that more one person was selected in households, 
the analyses have considered clustering. Because these 
were data taken from different independent samples 
of the populations over time, there were bound to be 
missing data. In our analysis we conducted complete case 
analyses by excluding missing values.27 Trend analysis was 
conducted using Cochrane trend test.28 29 A generalised 
linear model, using a Poisson distribution with a log-link 
function, was used to estimate adjusted prevalence ratios 
(aPR) accounting for clustering at the household level 
for each individual year, to address potential section bias. 
Although these datasets were obtained from independent 
cross-sectional studies, the pooled datasets combining all 
the years were analysed using cox proportional hazard 
models assigning the same follow-up time for each partic-
ipant via a robust variance estimator to consider repeated 
measurements of over time. This was because it has been 
shown that by imposing a constant follow-up time for 
all individuals, Cox model can be adopted to estimate 
prevalence rate ratios in cross sectional studies and this 
addresses selection biases.30 31 Study outcomes included 
malaria parasitaemia infection, care seeking, medication 
and ITN use. The independent variables were socioeco-
nomic status (SES), study areas (subcounties), sex and 
age groups (<5, 5–14 and ≥15 years). SES indices were 
generated using multiple correspondence analysis using 
the following variables; occupation of household head, 
primary source of drinking water, type of cooking fuel, 
ownership of household assets and ownership of live-
stock. The households were categorised into five socio-
economic quintiles and then classified into two groups 
for ease of comparisons. The first three lower quintiles 
were classified as the ‘poorest’ and the fourth and fifth 
quintiles classified as the ‘less-poor’.32–34 Backward selec-
tion criteria was used to include independent variables 
in the models and 95% CI of the prevalence rates were 
estimated in each case. All the analyses were weighted to 
account for sampling strategies. Sampling weights were 
created by dividing the population by the sample for each 
subgroup (age categories and study areas).
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Patient and public involvement
The research questions of this study were informed by 
patient’s priorities, experience and preferences and 
public were fully involved. Malaria disease is considered 
a priority to patients in this study areas because it can 
cause disabilities and deaths among patients. Similarly, 
poverty is a known problem that hinder many patients 
from accessing and utilising health interventions. Hence, 
examining the trends in burden of malaria in population 
subgroup is key to informing policies that reduce the 
burden and improving access to interventions and at the 
same time ensuring equity. Ethical considerations in this 
study required that a rigours community mobilisation be 
done through their advisory committees, meetings were 
held with health management teams in the local areas, 
participants were assured during consenting processes 
that patients who were found to have malaria parasites 
would be treated. For data collection we recruited field 
assistants from the same communities where we did our 
study and also with help of community health volunteers. 
Before conducting these surveys, we did not know who was 
positive for malaria and hence no patients conducted the 
recruitment. Results of this study will be shared with the 
Siaya county health management team for policy consid-
erations and with the Kenya national malaria control 
programme who are charged with responsibilities of iden-
tifying priorities areas for interventions. Results will also 
be shared in workshops involving community members.
results
descriptive epidemiology
Overall and in the pooled dataset, prevalence of malaria 
parasitaemia identified using microscopy was 36.5% 
with substantial variation between age groups (38.2% in 
children <5 years; 56.8% in children 5–14 years; 20.9% 
for adults ≥15 years). The prevalence of malaria parasi-
taemia was relatively stable between 2006 (38.3%) and 
2011 (39.8%), but reduced from 36.3% in 2012 to 34.5% 
in 2013. The proportion of individuals who received the 
first-line antimalarial medication, AL, in the 2 weeks prior 
to survey increased from 0% in 2006 to 44.0% in 2013 
(table 1).
Association of malaria infection, care seeking, medication use 
and Itn use with socioeconomic status
In the pooled data (n=11 383), prevalence of malaria 
infection was significantly higher among poor individ-
uals compared with less-poor overall (39.9% vs 33.5%; 
aPR=1.17; 95% CI 1.11 to 1.23). The prevalence of malaria 
infection was also significantly higher in poor individuals 
in each age group (children <5 years: aPR=1.20 (95% 
CI 1.11 to 1.31); children 5–14 years: aPR=1.13 (95% CI 
1.06 to 1.21)); adults ≥15 years: aPR=1.18 (95% CI 1.05 
to 1.33)). There was no clear trend in malaria prevalence 
by SES either overall or stratified by age group over time 
for the pooled analysis (table 3). For the pooled data, 
there was no significant difference in the proportion of 
individuals who sought care for illness between poor and 
less-poor households (61.1% vs 62.5%, aPR=0.99 (0.95 to 
1.03)) overall or by age group and year (table 4). Overall, 
medication use was similar among the poorest individ-
uals and less poor (73.2% vs 76.2%, aPR=0.95 (0.92 to 
1.00)). However, poorest individuals were less likely to 
use a recommended first-line antimalarial medication 
(ie, AL or quinine for pregnant women) among those 
reporting fever in the 2 weeks prior to survey (18.8% 
vs 22.1%, aPR=0.81 (0.72 to 0.91)). Poorest households 
were slightly less likely to report ITN use the night prior 
to the survey (55.2% vs 57.8%, aPR=0.95 (0.91 to 0.99)).
trends in malaria parasite prevalence and malaria indicators 
from 2006 to 2013 by ses
Trends analysis for the period 2006–2013, showed non-sig-
nificant change in parasitaemia (overall trend p=0.2560), 
among poorest (p=0.235) or among less poor (p=0.254) 
over time. However, among children 5–15 years the 
burden significant reduced among wealthier individuals 
(trend test p=0.007) but not among poorest individuals 
(p=0.158). Care seeking for fever among poorest individ-
uals did not change (p=0.059) but significantly increased 
among less poor individuals over time (p=0.012). Overall 
ITN use significantly increased between 2006 and 2013, 
and also increased among poorest individuals (p<0.001) 
and among those less poor (p<0.001). Utilisation of medi-
cation for malaria increased in both the poorest and less 
poor individuals (p<0.001) overtime. ITN use also signifi-
cantly increased over time in both groups and the gap 
were narrower over time (p<0.001) (table 4).
dIsCussIOn
The study has established socioeconomic inequalities 
in the distribution of malaria parasitaemia between the 
poorest and the less poor with the poorest populations, 
across all age groups over time bearing the highest 
burden. Overall trends showed no significant change in 
prevalence in the 8 years representing diminishing socio-
economic inequalities, and equity gains for the poor indi-
viduals. Although there were no significant differences in 
care-seeking behaviour between socioeconomic groups, 
poorest individuals were less likely to use the most effec-
tive antimalarial medications, AL and quinine, which 
have been the recommended first-line therapies in Kenya 
since 2006.12 26 Statistically significant difference in ITN 
use between the poorest and less poor was negligible 
representing lack of socioeconomic inequalities which 
can be perhaps attributed to intensified distribution of 
LLINs over time, which increased availability of ITNs 
in the households hence the increase in probability of 
usage. However, it’s worthy to note that only half of the 
populations were using ITNs despite near equity in use.
The results are comparable to findings from the Kenya 
malaria indicator surveys, which showed that use of first-
line antimalarial medications, ITN ownership and use 
were highest among wealthier quintiles while malaria 
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prevalence were lower in wealthier households between 
2007 and 2015.5 7 8 In 2011, the national malaria control 
programme launched the first nationwide mass distribu-
tion of free ITNs with the goal of universal coverage14 
and as a result, this study showed increased use of ITNs 
across the study period but use was unequally distributed 
between poorest and wealthier households. Results from 
Kenya national surveys already showed higher propor-
tions of ITN ownership among wealth quintiles over 
time.5 7 8
Similarly, a multicountry study had showed that house-
hold ownership of ITNs varied from 5% to greater than 
60%, and was equitable by urban/rural and wealth quin-
tile status among 13 (52%) of 25 countries.35 Although, 
there were no evidence of socioeconomic inequalities in 
care-seeking behaviour for fever, poor individuals were 
less likely to use the recommended first-line antimalarial 
medications, AL and quinine for pregnant women.10 12 26 It 
has already been documented that the success of malaria 
control depends on high level of coverage of interven-
tions and use of effective and recommended antimalarial 
but utilisation has remained low.35 A previous study had 
suggested that the use of AL was higher in children from 
the lowest wealth quintile compared with the highest 
wealth quintile because of policies that systematically 
affected access to malaria treatment for children such 
as cost of the medicines.36 Prior to introduction of the 
Affordable Medicine Facility—malaria in Kenya in 
2010, AL was significantly more expensive than other 
non-recommended antimalarial medicines in the private 
sector.37 Evidence from a study from rural western Kenya 
showed that when adults are uncertain that fever is due 
to malaria, they tend to choose the lowest-priced antima-
larial medicine from private-sector pharmacies and retail 
outlets.38 Therefore, when antimalarial medications were 
not available in public health facilities during the study 
period, individuals from poor households might have 
preferentially purchased non-recommended antimalarial 
medications in the private sector due to lower prices.13 
But despite equity in care seeking, use of medications, 
universal coverage or use of ITN and recommended 
medication, there still exists socioeconomic inequalities 
in burden of malaria parasitaemia. The study has estab-
lished that only fewer poor individuals used ITN but 
reasons as to why the poor are less likely to use nets may 
require further qualitative research. Generally, poor indi-
viduals are known to be vulnerable and live in impover-
ished conditions including lack of proper dwellings, poor 
knowledge, are prone to other illness and may even lack 
enough sleeping places which increase their risk to poor 
health outcomes.
In conclusion, socioeconomic inequalities in malaria 
burden still existed despite intensification of control 
programme but there was equity in care seeking and medi-
cation use. These results could imply that even perfectly 
equitable access to interventions could have an inequi-
table impact since risk is so strongly linked to poverty. 
The result contributes to the goals of Kenya Health Policy 
2014–2030 who aim was to achieve equity in the distribu-
tion of health services and interventions by 2030.39 Moni-
toring socioeconomic trends in the uptake and utilisation 
of malaria interventions is important to identify gaps in 
equity at the microeconomic level. Provision of interven-
tions for malaria control should aim to make them free to 
ensure equitable access among those least able to afford 
them especially among poor individuals40 and eliminate 
any economic or financial barriers.
strengths and limitations
The main strength of this paper is use of 8 years of pooled 
data which provided more power to assess socioeco-
nomic inequalities and equity. For lack of recent data, 
these historical data provided an opportunity to monitor 
socioeconomic inequalities and equity effect of interven-
tions. There did not exist enough studies assessing socio-
economic inequalities over time and progress towards 
achieving SDG goals by 2030. The study had three main 
limitations. First, the findings were based on data from 
cross-sectional surveys preventing any evaluation of 
cause-and-effect of SES on malaria indicators over time. 
However, robust statistical analysis including accounting 
for households clustering. Second, only households with 
children <5 years were included in the surveys based on 
protocol-specific objectives. Although all children <5 
years in a household were surveyed every year, only a 
small proportion of persons ≥5 years were included in the 
survey samples and lastly these results are generalisable to 
study area and not nationally. The difference in sampling 
techniques over time whereby in 2009, cluster sampling 
was used instead of systematic sampling may have in selec-
tion bias and may confound the interpretation of results.
COnClusIOn
Despite equity in ITN use over time and care seeking for 
fevers, malaria parasitaemia prevalence remains highest 
among poorest individuals in all age groups, which might 
be due in part to a lower likelihood of treatment with 
effective antimalarial medications when compared with 
less-poor individuals. The level of ITN usage still not 
optimal as only over half of the populations used ITNs 
which falls short of universal expectations, suggesting 
that additional strategies are necessary to achieve equity 
in prevention and treatment of malaria especially 
among poorest populations. Existence of socioeconomic 
inequalities in burden of malaria in a barrier to achieving 
universal health coverage and SGDs.
Author affiliations
1Center for Global Health, Kenya Medical Research Institute, Kisumu, Kenya
2Health Economics, Liverpool School of Tropical Medicine, Liverpool, UK
3Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease 
Control and Prevention, Atlanta, Georgia, USA
4Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, 
Kenya
5Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
6Health Economics, Liverpool School of Tropical Medicine, Liverpool, UK
7Department of Health Sciences, University of Warwick, Coventry, UK
M
edicine. Protected by copyright.
 o
n
 O
ctober 14, 2019 at Liverpool School of Tropical
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-033883 on 20 September 2019. Downloaded from 
9Were V, et al. BMJ Open 2019;9:e033883. doi:10.1136/bmjopen-2019-033883
Open access
Acknowledgements We are grateful to the communities of the KEMRI and 
CDC HDSS for their participation in and support of the HDSS. We also thank the 
numerous fields, clinical, data and administrative staff, without whom, this work 
would not have been possible; the KEMRI and CDC Research and Public Health 
Collaboration is a member of the INDEPTH Network. We are grateful to Dr Mary 
Hamel, who was the principal investigator for the surveys conducted between 2006 
and 2011. This paper was published with the permission of the Director, KEMRI.
Contributors MD, VW, SK conceived and designed the study. MD, VW, SK 
coordinated and performed the study. VW analysed the data. VW, MD, SK, AMB, 
AMS, SPK, PP-H, FOtK, and LWN drafted manuscript. All authors read and approved 
the final manuscript.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Data may be obtained from a third party and are not 
publicly available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. WHO. World malaria report 2018 2018.
 2. World Health Organization. World malaria report 2016. Geneva: 
WHO, 2016.
 3. Noor AM, Kirui VC, Brooker SJ, et al. The use of insecticide treated 
nets by age: implications for universal coverage in Africa. BMC 
Public Health 2009;9:369.
 4. Tizifa TA, Kabaghe AN, McCann RS, et al. Prevention efforts for 
malaria. Curr Trop Med Rep 2018;5:41–50.
 5. National Malaria Control Programme N. Kenya malaria indicator 
survey 2015. Nairobi, Kenya and Rockville, Maryland, USA: NMCP, 
KNBS, and ICF International, 2016.
 6. MoH. Kenya National health accounts 2012/13. Nairobi, Kenya: 
Ministry of Health, 2015.
 7. National Malaria Control Programme(NMCP). Kenya malaria indicator 
survey 2007. Nairobi, Kenya and Rockville, Maryland, USA: NMCP, 
KNBS, and NCAPD, 2009.
 8. National Malaria Control Programme(NMCP). Kenya malaria indicator 
survey 2010. Nairobi, Kenya and Rockville, Maryland, USA: NMCP, 
KNBS, and ICF International, 2011.
 9. Desai M, Buff AM, Khagayi S, et al. Age-Specific malaria mortality 
rates in the KEMRI/CDC health and demographic surveillance 
system in Western Kenya, 2003-2010. PLoS One 2014;9:e106197.
 10. MOH. National Guidelines for Diagnosis, Treatment & Prevention of 
Malaria for Health Workers. Nairobi, Kenya: Ministry of Health,Kenya, 
2006.
 11. Zurovac D, Njogu J, Akhwale W, et al. Effects of revised diagnostic 
recommendations on malaria treatment practices across age groups 
in Kenya. Trop Med Int Health 2008;13:784–7.
 12. Division of Malaria_Control. National guidelines for the diagnosis, 
treatment and prevention of malaria in Kenya. Nairobi Kenya: Kenya 
Ministry of Public Health and Sanitation, 2010.
 13. Hamel MJ, Adazu K, Obor D, et al. A reversal in reductions of 
child mortality in Western Kenya, 2003-2009. Am J Trop Med Hyg 
2011;85:597–605.
 14. Division of Malaria Control. Evaluation of the 2011 mass long-
lasting insecticide treated net (LLIN) distribution campaign: phase 
1 and 2 report. Nairobi Kenya: Kenya Ministry of Public Health and 
Sanitation, 2013.
 15. Ev D, Wagstaff A, Rutten F. Equity in the finance and delivery of 
health care: an international perspective. Oxford University Press, 
1992.
 16. Niessen LW, Mohan D, Akuoku JK, et al. Tackling socioeconomic 
inequalities and non-communicable diseases in low-income and 
middle-income countries under the sustainable development 
agenda. The Lancet 2018;391:2036–46.
 17. Chuma J, Abuya T, Memusi D, et al. Reviewing the literature 
on access to prompt and effective malaria treatment in Kenya: 
implications for meeting the Abuja targets. Malar J 2009;8:243.
 18. Were V, Buff AM, Desai M, et al. Socioeconomic health inequality in 
malaria indicators in rural Western Kenya: evidence from a household 
malaria survey on burden and care-seeking behaviour. Malar J 
2018;17:166.
 19. Onwujekwe O, Hanson K, Uzochukwu B. Do poor people use poor 
quality providers? Evidence from the treatment of presumptive 
malaria in Nigeria. Trop Med Int Health 2011;16:1087–98.
 20. Onwujekwe O, Hanson K, Uzochukwu B. Examining inequities in 
incidence of catastrophic health expenditures on different healthcare 
services and health facilities in Nigeria. PLoS One 2012;7:e40811.
 21. Adazu K, Lindblade KA, Rosen DH, et al. Health and demographic 
surveillance in rural Western Kenya: a platform for evaluating 
interventions to reduce morbidity and mortality from infectious 
diseases. Am J Trop Med Hyg 2005;73:1151–8.
 22. Odhiambo FO, Laserson KF, Sewe M, et al. Profile: the KEMRI/CDC 
Health and Demographic Surveillance System--Western Kenya. Int J 
Epidemiol 2012;41:977–87.
 23. Kenya National Bureau of Statistics (KNBS) and ICF_Macro. Kenya 
demographic and health survey 2008–09. Calverton, Maryland, USA, 
2010.
 24. Kenya National Bureau of Statistics (KNBS) and ICF_Macro. Kenya 
demographic and health survey 2008–09. Calverton, Maryland, USA, 
2015.
 25. World Bank. Nyanza Province poverty incidence maps, 2014. 
Available: http://siteresourcesworldbankorg
 26. Division of Malaria Control. National guidelines for the diagnosis, 
treatment and prevention of malaria in Kenya. Nairobi Kenya: Kenya 
Ministry of Public Health and Sanitation, 2012.
 27. Rafferty A, Walthery P, King-Hele S. Analysing change over time: 
repeated crosssectional and longitudinal survey data. UK data 
service, University of Essex and University of Manchester 2015.
 28. Cuzick J. A Wilcoxon‐type test for trend. Statistics in medicine 
1985;4:543–7.
 29. Armitage P. Tests for linear trends in proportions and frequencies. 
Biometrics 1955;11:375–86.
 30. Lee J, Chia KS. Estimation of prevalence rate ratios for cross 
sectional data: an example in occupational epidemiology. Occup 
Environ Med 1993;50:861–2.
 31. Aviisah PA, Dery S, Atsu BK, et al. Modern contraceptive use among 
women of reproductive age in Ghana: analysis of the 2003-2014 
Ghana demographic and health surveys. BMC Womens Health 
2018;18:141.
 32. Su-Myat KK, Tibeiro JJSde, Kumar P. An integrated approach to 
regression analysis in multiple correspondence analysis and copula 
based models. J Stat Appl Probab 2012;1:67–87.
 33. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop 
Med Hyg 2001;64(1_suppl):85–96.
 34. Amek N, Vounatsou P, Obonyo B, et al. Using health and 
demographic surveillance system (HDSS) data to analyze 
geographical distribution of socio-economic status; an experience 
from KEMRI/CDC HDSS. Acta Trop 2015;144:24–30.
 35. Team AIE. Independent evaluation of phase 1 of the Affordable 
medicines Facility—malaria (AMFm): multi-country independent 
evaluation report: final report: supplementary report on act use 
based on household surveys: ICF international and London school of 
hygiene and tropical medicine 2012.
 36. Ministry of Public Health and Sanitation (MOPHS). National malaria 
strategy 2009-2017. in: control DOM, ED. Nairobi. Kenya: Division of 
Malaria Control, 2009.
 37. Goodman C, Tougher S, Mann A, et al. Independent evaluation of 
phase 1 of the Affordable medicines Facility-malaria (AMFm), Multi-
Country independent evaluation final report 2012.
 38. Cohen J, Dupas P, Schaner S. Price subsidies, diagnostic tests, 
and targeting of malaria treatment: evidence from a randomized 
controlled trial. Am Econ Rev 2015;105:609–45.
 39. MOH. Kenya health policy 2014-2030—Towards attaining the highest 
standard of health. Nairobi, Kenya: Kenya Ministry of Health, 2014.
 40. Noor AM, Amin AA, Akhwale WS, et al. Increasing coverage and 
decreasing inequity in insecticide-treated bed net use among rural 
Kenyan children. PLoS Med 2007;4:e255.
M
edicine. Protected by copyright.
 o
n
 O
ctober 14, 2019 at Liverpool School of Tropical
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-033883 on 20 September 2019. Downloaded from 
